Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEGFR1 Peptide Vaccine + Gemcitabine in Advanced Pancreatic Cancer
NCT00683085Phase 2Terminated
- Sponsor
- The University of Tokyo
- Start
- May 2008
- Primary completion
- May 2009
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of VEGFR1-A02-770 in pancreatic cancer (PC), sponsored by The University of Tokyo. Started May 2008; status: terminated.
02
Drugs
VEGFR1-A02-770
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00683085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683085.